SJS Investment Consulting’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $755 | Sell |
6
-1
| -14% | -$126 | ﹤0.01% | 964 |
|
|
2025
Q1 | $775 | Sell |
7
-3
| -30% | -$332 | ﹤0.01% | 1092 |
|
|
2024
Q4 | $1.37K | Buy |
10
+4
| +67% | +$546 | ﹤0.01% | 888 |
|
|
2024
Q3 | $692 | Sell |
6
-3
| -33% | -$346 | ﹤0.01% | 1207 |
|
|
2024
Q2 | $1.24K | Buy |
9
+5
| +125% | +$689 | ﹤0.01% | 946 |
|
|
2024
Q1 | $552 | Hold |
4
| – | – | ﹤0.01% | 1252 |
|
|
2023
Q4 | $528 | Buy |
4
+1
| +33% | +$132 | ﹤0.01% | 1237 |
|
|
2023
Q3 | $338 | Hold |
3
| – | – | ﹤0.01% | 1343 |
|
|
2023
Q2 | $283 | Buy |
+3
| New | +$283 | ﹤0.01% | 1327 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$358 | – | 1614 |
|
|
2022
Q4 | $358 | Sell |
3
-1
| -25% | -$119 | ﹤0.01% | 1304 |
|
|
2022
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1364 |
|
|
2022
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1122 |
|